• Publications
  • Influence
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer.
BACKGROUND For patients with locally or regionally advanced non-small-cell lung cancer radiation is the standard treatment, but survival remains poor. We therefore conducted a randomized trial toExpand
  • 1,083
  • 13
Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.
PURPOSE The main objectives of this study were (a) to ascertain the feasibility and toxicity of preoperative twice-daily radiation therapy and concurrent chemotherapy, surgery, and postoperativeExpand
  • 265
  • 10
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.
We conducted a prospective, randomized study to clarify the role of radiotherapy of the primary tumor in limited small-cell cancer of the lung. After stratification for sex and for performance scoreExpand
  • 435
  • 9
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
BACKGROUND Patients with advanced cancer frequently experience clinically significant anemia, which is often exacerbated by myelosuppressive chemotherapy. Consistent with the anemia of chronicExpand
  • 195
  • 6
Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
PURPOSE This phase II trial was designed to evaluate the feasibility, toxicity, response rates, and survival for neoadjuvant chemotherapy and radiotherapy (RT) followed by surgical resection in newlyExpand
  • 210
  • 5
Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes.
The myelodysplastic syndrome (MDS) comprises a group of clonal hematopoietic disorders derived from an abnormality affecting a multipotent hematopoietic stem cell. Despite trials testing numerousExpand
  • 222
  • 4
Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B.
The efficacy of the addition of intensive therapy with daunorubicin (45 mg/m2 IV on days 1, 2, 3) to an otherwise identical induction program consisting of vincristine, prednisone, and L-asparaginaseExpand
  • 121
  • 4
  • PDF
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B.
By Kanti R. Rai, James F. Holland, Oliver J. Glidewell, Vivian Weinberg, Kurt Brunner, J. P. Obrecht, Harvey D. Preisler, Ismat W. Nawabi, David Prager, Robert W. Carey, M. Robert Cooper, FaridExpand
  • 130
  • 4
Clostridial oncolysis in man
Resume L'activite antineoplasique du C. butyricum a ete demontree sur l'adenocarcinome spontane des souris et sur des tumeurs humaines. Parmi les souris montrant l'effet oncolytique du clostridium,Expand
  • 98
  • 3